`

Bicycle Therapeutics

Biotechnology Research

Specialities :
Drug discovery
Phage display
Peptide therapeutics
And biotechnology
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$200.0M
size-icon Size
201 - 500

Frequently Asked Questions About Bicycle Therapeutics

What does Bicycle therapeutics do?+

Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of medicines to treat cancer and other diseases. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. The company is evaluating zelenectide pevedotin, previously BT8009, a Bicycle Toxin Conjugate (BTC) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC molecule targeting...

What are Bicycle therapeutics's specialties? +

Drug discovery,phage display,peptide therapeutics,and biotechnology

What is Bicycle therapeutics's industry? +

Bicycle therapeutics operates in the Biotechnology research industry.

What is Bicycle therapeutics's revenue? +

Bicycle therapeutics's revenue is 11m - 100m

What is Bicycle therapeutics's company size? +

Bicycle therapeutics has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.